"Accuray is thrilled to attend ASTRO 2021 and have the opportunity to engage with our valued customers. We are focused on positioning them for success in an ever evolving healthcare environment," said Suzanne Winter, president of Accuray.
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
